Immunovant (IMVT) Return on Capital Employed Growth (1y) (2020 - 2026)
Immunovant (IMVT) Return on Capital Employed Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | 31,429.00 |
| 4 | BeOne Medicines | 473.74 Bn | 468.95 Bn | 1.35 Bn | 1,805.00 |
| 5 | Vertex Pharmaceuticals | 122.07 Bn | 114.82 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 70.00 Bn | 61.24 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn | 2,400.00 |
| 10 | Immunovant | 7.35 Bn | 6.45 Bn | - | -11,196.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11,196.00 |
| Dec 31, 2025 | -6,334.00 |
| Sep 30, 2025 | -10,538.00 |
| Jun 30, 2025 | -9,266.00 |
| Mar 31, 2025 | -2,682.00 |
| Dec 31, 2024 | -8,877.00 |
| Sep 30, 2024 | -2,176.00 |
| Jun 30, 2024 | 12,931.00 |
| Mar 31, 2024 | 13,295.00 |
| Dec 31, 2023 | 17,185.00 |
| Sep 30, 2023 | 17,917.00 |
| Jun 30, 2023 | 3,735.00 |
| Mar 31, 2023 | 608.00 |
| Dec 31, 2022 | 415.00 |
| Sep 30, 2022 | -1,560.00 |
| Jun 30, 2022 | -3,994.00 |
| Mar 31, 2022 | -4,979.00 |
| Dec 31, 2021 | -4,495.00 |
| Sep 30, 2021 | -6,572.00 |
| Jun 30, 2021 | -1,689.00 |